Safety of Liraglutide in Subjects With Liver Impairment and in Subjects With Normal Liver Function

Clinical trial NCT01507389 · COMPLETED

Trial details

NCT number: NCT01507389
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Diabetes Mellitus, Type 2

Start date: 2006-03-01
Primary completion: 2006-06-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.